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CLINICAL CASE

SKIN MANIFESTATIONS IN YOUNG MILITARY PERSONNEL
DIAGNOSED WITH COVID-19, PERU
MANIFESTACIONES CUTÁNEAS EN PERSONAL MILITAR JOVEN CON DIAGNÓSTICO COVID 19 - PERÚ
Richard J. Febres-Ramos1,a, Stephany Keila Vilchez-Bravo2,b
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ABSTRACT
COVID-19 is a highly contagious respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2.
The infection has been reported to demonstrate different types of skin manifestations including urticarial, maculopapular,
papulovesicular, purpuric, livedoid, and thrombotic-ischemic lesions. Given the high mortality rate of the infection, timely
and accurate identification of relevant skin manifestations can play a key role in early diagnosis and management.
Skin manifestations, a well-known effect of viral infections, are beginning to be reported in patients with COVID-19
disease. These manifestations most often are morbilliform rash, hives, vesicular rashes, acral lesions, and livedoid rashes.
Some of these skin manifestations arise before the signs and symptoms most commonly associated with COVID-19,
suggesting that they may be showing signs of COVID-19
Bibliographic reports showed great heterogeneity in the skin manifestations associated with COVID-19, as well as in their
latency periods and associated extracutaneous symptoms. Pathogenic mechanisms are unknown, although the functions
of an overactive immune response, complement activation and microvascular injury have been hypothesized. Based on
our experience and bibliographic data, we subdivide reported skin lesions into six main clinical patterns: (I) urticarial rash;
(II) erythematous-maculopapular-morbilliforma confluent rash; (III) papulovesicular exanthemum; (IV) chilblain-like acral
pattern; (V) livedo reticularis–livedo racemosa-like pattern; and (VI) purpurico "vasculytic" pattern. These six patterns can
be fused into two main groups: the first – inflammatory and exanthemum – includes the first three groups mentioned
above, and the second includes vasculopathic and vasculytic lesions of the last three groups.
We can conclude that skin manifestations are similar to skin involvement that occurs during common viral infections.
Key words: Skin manifestations; Itching; Coronavirus infection; COVID-19 (source: MeSH NLM).

RESUMEN
La enfermedad por coronavirus es una infección del tracto respiratorio altamente contagioso causado por el coronavirus
del síndrome respiratorio agudo grave 2. La infección se ha divulgado para demostrar diferentes tipos de manifestaciones
cutáneas incluyendo lesiones urticariales, maculopapulares, papulovesiculares, purpuricas, livedoides, y trombóticaisquémica. Dada la alta tasa de mortalidad de la infección, la identificación oportuna y precisa de las manifestaciones
cutáneas puede desempeñar un papel clave en el diagnóstico y manejo tempranos.
Las manifestaciones cutáneas son comunes en infecciones virales, en el caso de la enfermedad por coronavirus se han
reportado diversas manifestaciones, entre ellas las más comunes son: erupción morbilliforme, urticaria, erupciones
vesiculares, lesiones acrales, y erupciones livedoides. Algunas de estas manifestaciones cutáneas surgen antes de los
signos y síntomas más comúnmente asociados con COVID-19, lo que sugiere que podrían estar presentando signos de
COVID-19.
Los informes bibliográficos mostraron una gran heterogeneidad en las manifestaciones cutáneas asociadas a COVID-19,
así como en sus períodos de latencia y los síntomas extracutáneos asociados. Se desconocen los mecanismos patógenos,
aunque se han hipotetizado las funciones de una respuesta inmune hiperactiva, la activación del complemento y la
lesión microvascular. Basándonos en nuestra experiencia y los datos bibliográficos, subdividimos las lesiones cutáneas
notificadas en seis patrones clínicos principales: (I) erupción urticarial; (II) erupción eritematosa-maculopapularmorbilliforme confluente; (III) exantema papulovesicular; (IV) patrón acral similar a la chilblain; (V) patrón livedo
reticularis–livedo racemosa-like; y (VI) patrón "vasculítico" purpúrico. Estos seis patrones se pueden fusionar en dos grupos
principales: el primero - inflamatorio y exantematoso - incluye los tres primeros grupos mencionados anteriormente, y el
segundo incluye las lesiones vasculopáticas y vasculíticas de los últimos tres grupos.
Podemos concluir que las manifestaciones cutáneas son similares a la afectación cutánea que ocurre durante las
infecciones virales comunes.
Palabras clave: Manifestaciones cutáneas; Prurito; Infección por coronavirus; COVID-19 (fuente: DeCS BIREME).
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INTRODUCTION
On March 11, 2020, the World Health Organization
(WHO) declared a worldwide pandemic due to a new
disease denominated COVID-19, a virus which was
described as causing pneumonia of unknown origin,
in Wuhan, China in December 2019, later named
SARS-CoV-2(1).

Skin manifestations, a well-known effect of viral
infections, are starting to be seen in adult patients
with COVID-19 disease. These manifestations most
often are morbilliform rash, hives, vesicular rashes,
acral lesions, and livedoid rashes. Some of these skin
manifestations arise before the signs and symptoms
most commonly associated with COVID-19,
suggesting that they may be showing signs of
COVID-19(3).
Bibliographic reports showed great heterogeneity in
the skin manifestations associated with COVID-19,
as well as in their latency periods and associated
extracutaneous symptoms. Pathogenic mechanisms
are unknown, although the functions of an overactive
immune response, complement activation and
microvascular injury have been hypothesized(4).
The intensity of viral infections in the skin and
mucosa depends on many factors such as gender,
age, comorbidities, immune status, etc. This skin
infection, when replicating exponentially, can
generate cell destruction and tissues hyperplasia,
evident in the various lesions it generates, many
aspects of coronavirus disease are still unknown, it
is not ruled out that after a period of time they may
reactivate and generate new lesions skin, that is why
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Next, three cases of patients who were positive
for COVID-19 by immunochromatographic test
are reported that presented very similar skin
manifestations, had a favorable evolution and did
not present complications.

DESCRIPTION OF CLINICAL CASES
CASE 1
It is presented as the case of a 24-year-old male
patient without significant history, in his second
year of military service, denies allergies. An
immunochromatographic test in blood where
reactive IgM was obtained. He presented mild
symptoms as sore throat and nasal congestion,
he also received symptomatic treatment with
paracetamol, performed social isolation on Centro
de Salud Militar for 14 days, on its fifth day of isolation
presented diverse skin eruptions in the dorsal
region, including pruritic papulopustular (Figure 1a),
chlorphenamine and dicloxacillin were administered
orally and symptomatology improved. After the first
week of treatment, dermal lesions improved and the
patient no longer presented itching, which is why
the treatment was suspended, after three months
the dermal lesions have decreased by 80% (Figure
1b). The patient did not present other complications.

CASO CLÍNICO

COVID-19 is a respiratory tract infection highly
contagious caused by SARS-CoV-2. Viral infection has
been divulged to demonstrate different types of skin
manifestations, including urticarial, maculopapular,
papulovesicular, purpuric, livedoid, and thromboticischemic lesions. Given the high mortality rate of
the infection, timely identification of diverse skin
manifestations may play a key role in the diagnosis
and management of the disease as well as the
identification of disease state or phase(2).

the reports and new studies about this disease are of
great help(5).

CASE 2
A 24-year-old male patient, with no significant
history, in his second year of military service with
COVID-19 diagnosis by immunochromatographic
test with reactive IgM, presented on his fifth day
of illness papulopustular skin rashes in the dorsal
region and pustular lesions in the genian, (Figure 2a
and 2b) received treatment with chlorphenamine
for 05 days improving symptoms, another
immunochromatographic test was performed at
21 days where reactive IgG is evidenced, after 03
months the lesions have improved but have not yet
disappeared (Figure 2c), the patient was discharged
without presenting complications.
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Figure 1. (A) Pruritic papulopustular eruption in the dorsal region. (B) Papulopustular lesion resolving at
80%, after 03 months.

CASE 3
We present the case of a 20-year-old man, with no
significant history, without comorbidities, in his
first year of military service, denies allergies with a
diagnosis of COVID-19 by immunochromatographic
test. He presented mild symptoms receiving only
symptomatic treatment, on his seventh day of
illness he presented pruritic maculopapular lesions
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in the dorsal region (Figure 3a), he only received
oral chlorphenamine treatment for 03 days and
dicloxacillin for 05 days, symptoms improve but
lesions do not disappear, patient he was discharged
without presenting complications; after 03 months
lesions do not disappear (Figure 3b).
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Figure 2. (A) Pruritic papulopustular eruption in dorsal region. (B) Pustular lesion in the genian region.(C)
Papulopustular lesion in dorsal region, after 03 months
DISCUSSION
It shall be noted that earlier and timely identification
of skin manifestations may perform a key role in the
early diagnosis and management of the disease,
thus identifying the stage or phase in which the
disease is found(2). In Case 01 presented, clinical skin
manifestations are pruritic papulopustular-type
cutaneous clinical manifestations are evident (Figure
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1a) that began on the fifth day after the diagnosis
was made with a reactive immunochromatographic
test: IgM, which with antihistamine treatment
and antibiotic therapy have decreased the lesions
by 80% at 03 months (Figure 1b). These dermal
lesions are mostly accompanied by intense itching,
thus generating scratching leads to excoriative
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Figure 3. (A) Pruritic maculopapular lesions in dorsal region. (B) Maculopapular lesions in dorsal region by
resolution, after three months.
lesions, which can later become infected, so timely
management is crucial(3).
In
Case
02,
after
diagnosis
by
immunochromatographic reactive test: IgM
on the fifth day presented skin eruption of
papulopustular type in dorsal region and pustular
lesions in genian region (Figures 2a and 2b). As
it is described in bibliographic research, skin
manifestations associated with COVID-19 present
a high heterogeneity(4). He received treatment
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with antihistamines, in this way symptomatology.
After three months, lesions improved but still
persist (Figure 2c). Pathogenic mechanisms of
skin manifestations are still unknown, in this way
different hypotheses have been postulated, for
instance: overactive immune response, complement
activation and microvascular injury(4).
Case
03
shows
a
patient
with
immunochromatographic test diagnosis who
presented pruritic maculopapular lesions (Figure

5

Revista de la Facultad de Medicina Humana, Vol. 21 [2021], Iss. 1, Art. 24

3a). According to bibliographic data, we may rate
this type of lesion in clinical pattern type II: confluent
er ythematous-maculopapular-mor billifor m
eruption, this clinical pattern belonging to the
Group: inflammatory and exanthematous(4). He
received antihistamine treatment and antibiotic
therapy. As a result, the symptomatology improved
and there were no complications. Lesions are still
presented after three months (Figure 3b).

or manifest at the cutaneous-mucosal level as part
of a general picture(6).
Maintaining a healthy lifestyle, adequate control of
comorbidities and an adequate immune status will
reduce the intensity of viral infections of the skin
and mucosa.

CONCLUSION
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The skin, including the mucous membranes, is an
organ that very frequently presents viral infections.
These infections can be located primarily in the skin

It is concluded that the cutaneous manifestations
can be multiple, both as initial, intermediate and
final symptoms of the Covid-19 disease, to be taken
into account for the evaluation of patients with
infection by the Sars-cov2 virus, which in its great
Most respond favorably to the use of antihistamines
and antibiotics, the timely management of these
skin lesions is very important to avoid later
complications. It is also important to know the skin
manifestations of Covid-19, since this helps to know
the totality of clinical manifestations of this new
disease.

Finally, it is important to remember that the intensity
of viral infections in the skin and mucosa depend on
many factors such as gender, age, comorbidities,
immune status, etc.(5). As were the cases reported
in these three young patients belonging to the
Peruvian army, without comorbidities and who are
in good physical condition, all these aforementioned
factors prevented future complications.
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